HomeHomeHome
Home
Analytes/Measurements View

The Analytes/Measurements View lists the analytes (chemical entities) and the hearing measurements that serve as markers for newborn screening conditions. This view includes the analytes you selected on a previous screen, a short name, and a Logical Observation Identifiers Names and Codes (LOINC®) Number that may be used in electronic laboratory reports. Click on an analyte name to view related conditions, or to see answer lists for measurements with categorical values. For measurements with numeric values, the view also includes the units of measurement.

     
Analyte Name1
Choose analyte to view related conditions
Analyte
Short Name2
LOINC
Number3
Units4
Point of Care
  Hearing
      Newborn hearing screen - left Hear-L 54108-6 Answer list
      Newborn hearing screen - right Hear-R 54109-4 Answer list
      Newborn hearing screen method Hear-Meth 54106-0 Answer list
  Critical Congenital Heart Disease
      CCHD newborn screening protocol used CCHD protocol 73697-5  
      Difference between preductal and postductal saturation Pre-post difference 73696-7 %
      Postductal (either foot) oxygen saturation Postductal O2 sat 59418-4 %
      Preductal (right hand) oxygen saturation Preductal O2 sat 59407-7 %
      CCHD newborn screening interpretation   73700-7 Answer list
MS/MS
  Amino Acid
      5-Oxoproline+Pipecolate OXOPRO + PIPA 53232-5 umol/L
      5-Oxoproline+Pipecolate/Phenylalanine [OXOPRO + PIPA] / PHE 53394-3 {ratio}
      Alanine+Beta Alanine+Sarcosine ALA + BALA + SARC 53150-9 umol/L
      Alloisoleucine+Isoleucine+Leucine+Hydroxyproline AILE + ILE + LEU + OHPRO 53152-5 umol/L
      Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine [AILE + ILE + LEU + OHPRO + VAL] / [PHE + TYR] 53393-5 {ratio}
      Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine [AILE + ILE + LEU + OHPRO] / ALA 53154-1 {ratio}
      Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine [AILE + ILE + LEU + OHPRO] / PHE 53153-3 {ratio}
      Arginine ARG 47562-4 umol/L
      Arginine/Ornithine ARG / ORN 75214-7 {ratio}
      Arginine/Phenylalanine ARG / PHE 53398-4 {ratio}
      Argininosuccinate ASA 53062-6 umol/L
      Argininosuccinate/Arginine ASA / ARG 53200-2 {ratio}
      Asparagine+Ornithine ASN + ORN 53155-8 umol/L
      Asparagine+Ornithine/Phenylalanine [ASN + ORN] / PHE 53396-8 {ratio}
      Asparagine+Ornithine/Serine [ASN + ORN] / SER 53395-0 {ratio}
      Aspartate ASP 47573-1 umol/L
      Citrulline CIT 42892-0 umol/L
      Citrulline/Arginine CIT/ARG 54092-2 {ratio}
      Citrulline/Phenylalanine CIT / PHE 53157-4 {ratio}
      Citrulline/Tyrosine CIT / TYR 53399-2 {ratio}
      Glutamate GLU 47623-4 umol/L
      Glycine GLY 47633-3 umol/L
      Histidine HIS 47643-2 umol/L
      Homocitrulline HOMOCIT 53158-2 umol/L
      Lysine LYS 47689-5 umol/L
      Methionine MET 47700-0 umol/L
      Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline MET / [AILE + ILE + LEU + OHPRO] 53397-6 {ratio}
      Methionine/Phenylalanine MET / PHE 53156-6 {ratio}
      Ornithine/Citrulline ORN / CIT 75215-4 {ratio}
      Phenylalanine PHE 29573-3 umol/L
      Phenylalanine/Tyrosine PHE / TYR 35572-7 {ratio}
      Proline PRO 47732-3 umol/L
      Proline/Phenylalanine PRO / PHE 53392-7 {ratio}
      Serine SER 47742-2 umol/L
      Succinylacetone SUAC 53231-7 umol/L
      Threonine THR 47784-4 umol/L
      Tryptophan TRP 53159-0 umol/L
      Tyrosine TYR 35571-9 umol/L
      Valine VAL 47799-2 umol/L
      Valine/Phenylalanine VAL/PHE 53151-7 {ratio}
      Amino acidemias newborn screen interpretation   46733-2 Answer list
  Fatty Acid Oxidation
      3-Hydroxybutyrylcarnitine (C4-OH) C4OH 50102-3 umol/L
      3-Hydroxydecenoylcarnitine (C10:1-OH) C10:1OH 53182-2 umol/L
      3-Hydroxydodecanoylcarnitine (C12-OH) C12OH 53189-7 umol/L
      3-Hydroxydodecenoylcarnitine (C12:1-OH) C12:1OH 53188-9 umol/L
      3-Hydroxyhexanoylcarnitine (C6-OH) C6OH 53173-1 umol/L
      3-Hydroxylinoleoylcarnitine (C18:2-OH) C18:2OH 50109-8 umol/L
      3-Hydroxyoleoylcarnitine (C18:1-OH) C18:1OH 50113-0 umol/L
      3-Hydroxypalmitoleylcarnitine (C16:1-OH) C16:1OH 50121-3 umol/L
      3-Hydroxypalmitoylcarnitine (C16-OH) C16OH 50125-4 umol/L
      3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) C16OH / C16 53201-0 {ratio}
      3-Hydroxystearoylcarnitine (C18-OH) C18OH 50132-0 umol/L
      3-Hydroxytetradecadienoylcarnitine (C14:2-OH) C14:2OH 53196-2 umol/L
      3-Hydroxytetradecanoylcarnitine (C14-OH) C14OH 50281-5 umol/L
      3-Hydroxytetradecenoylcarnitine (C14:1-OH) C14:1OH 53197-0 umol/L
      ABCD1 gene mutation analysis ABCD1 79568-2 Answer list
      Carnitine free (C0) C0 38481-8 umol/L
      Carnitine free (C0)/Palmitoylcarnitine (C16) C0 / C16 53233-3 {ratio}
      Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) C0 / [C16 + C18] 53235-8 {ratio}
      Carnitine free (C0)/Stearoylcarnitine (C18) C0 / C18 53234-1 {ratio}
      Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [C0 + C2 + C3 + C16 + C18:1 + C18] / CIT 53236-6 {ratio}
      Decadienoylcarnitine (C10:2) C10:2 53180-6 umol/L
      Decanoylcarnitine (C10) C10 45197-1 umol/L
      Decenoylcarnitine (C10:1) C10:1 45198-9 umol/L
      Dodecanoylcarnitine (C12) C12 45199-7 umol/L
      Dodecenoylcarnitine (C12:1) C12:1 45200-3 umol/L
      Hexanoylcarnitine (C6) C6 45211-0 umol/L
      Linoleoylcarnitine (C18:2) C18:2 45217-7 umol/L
      Lysophosphatidylcholine (C26:0) C26:0-LPC 79321-6 umol/L
      Lysophosphatidylcholine (C26:0) - HPLC C26:0-LPC-HPLC 79567-4 umol/L
      Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) C3DC / C10 75212-1 {ratio}
      Octanoylcarnitine (C8) C8 53175-6 umol/L
      Octanoylcarnitine (C8)/Acetylcarnitine (C2) C8 / C2 53176-4 {ratio}
      Octanoylcarnitine (C8)/Decanoylcarnitine (C10) C8 / C10 53177-2 {ratio}
      Octenoylcarnitine (C8:1) C8:1 53174-9 umol/L
      Oleoylcarnitine (C18:1) C18:1 53202-8 umol/L
      Palmitoleylcarnitine (C16:1) C16:1 53198-8 umol/L
      Palmitoylcarnitine (C16) C16 53199-6 umol/L
      Propionylcarnitine (C3)+Palmitoylcarnitine (C16) C3 + C16 75211-3 umol/L
      Stearoylcarnitine (C18) C18 53241-6 umol/L
      Stearoylcarnitine (C18)/Propionylcarnitine (C3) C18 / C3 53400-8 {ratio}
      Tetradecadienoylcarnitine (C14:2) C14:2 53190-5 umol/L
      Tetradecanoylcarnitine (C14) C14 53192-1 umol/L
      Tetradecenoylcarnitine (C14:1) C14:1 53191-3 umol/L
      Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) C14:1 / C2 53193-9 {ratio}
      Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) C14:1 / C12:1 53194-7 {ratio}
      Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) C14:1 / C16 53195-4 {ratio}
      Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) C14:1 / C14 70159-9 {ratio}
      Fatty acid oxidation defects newborn screen interpretation   46736-5 Answer list
  Fatty Acid Oxidation-Organic Acid
      3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) C8OH + C3DC 53178-0 umol/L
      3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) C8OH + C3DC / C4 53402-4 {ratio}
      3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) C8OH + C3DC / C10 53179-8 {ratio}
      Acetylcarnitine (C2) C2 50157-7 umol/L
      Butyrylcarnitine+Isobutyrylcarnitine (C4) C4 53166-5 umol/L
      Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) C4 / C2 53167-3 {ratio}
      Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) C4 / C8 53169-9 {ratio}
      Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) C4 / C3 53168-1 {ratio}
      Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) C5DC + C10OH 53183-0 umol/L
      Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) C5DC + C10OH / C5OH 53184-8 {ratio}
      Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) C5DC + C10OH / C4 53403-2 {ratio}
      Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) C5DC + C10OH / C8 53185-5 {ratio}
      Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) C5DC + C10OH / C16 53186-3 {ratio}
  Organic Acid
      3-Hydroxyisovalerylcarnitine (C5-OH) C5OH 50106-4 umol/L
      3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0) C5OH / C0 53171-5 {ratio}
      3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8) C5OH / C8 53172-3 {ratio}
      Acrylylcarnitine (C3:1) C3:1 53237-4 umol/L
      Formiminoglutamate FIGLU 53165-7 umol/L
      Glutarylcarnitine (C5-DC) C5DC 45207-8 umol/L
      Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH) C5DC + C6OH 67710-4 umol/L
      Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8) C5DC + C6OH / C8 67711-2 {ratio}
      Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16) C5DC + C6OH / C16 67701-3 {ratio}
      Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC) C5DC / C3DC 75216-2 {ratio}
      Isovalerylcarnitine+Methylbutyrylcarnitine (C5) C5 45216-9 umol/L
      Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2) C5 / C2 53239-0 {ratio}
      Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0) C5 / C0 53238-2 {ratio}
      Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8) C5 / C8 53401-6 {ratio}
      Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3) C5 / C3 53240-8 {ratio}
      Malonylcarnitine (C3-DC) C3DC 54462-7 umol/L
      Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH) C3DC + C4OH 67708-8 umol/L
      Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [C3DC + C4OH] / C10 75213-9 {ratio}
      Methylglutarylcarnitine (C6-DC) C6DC 53187-1 umol/L
      Methylmalonylcarnitine (C4-DC) C4DC 45222-7 umol/L
      Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH) C4DC + C5OH 67709-6 umol/L
      Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH) C4DC / C5OH 53181-4 {ratio}
      Propionylcarnitine (C3) C3 53160-8 umol/L
      Propionylcarnitine (C3)/Acetylcarnitine (C2) C3 / C2 53163-2 {ratio}
      Propionylcarnitine (C3)/Carnitine.free (C0) C3 / C0 53162-4 {ratio}
      Propionylcarnitine (C3)/Methionine C3 / MET 53161-6 {ratio}
      Propionylcarnitine (C3)/Palmitoylcarnitine (C16) C3 / C16 53164-0 {ratio}
      Tiglylcarnitine (C5:1) C5:1 53170-7 umol/L
      Organic acidemias newborn screen interpretation   46744-9 Answer list
Non-MS/MS
  Biotinidase
      Biotinidase [Enzymatic activity/volume] BIO 75217-0 nmoL/mL/min
      Biotinidase [Presence] BIO (presence) 38478-4 {presence}
      Biotinidase deficiency newborn screen interpretation   46761-3 Answer list
  Cystic Fibrosis
      CFTR gene mutations found CFTR-Mut 54083-1 Specific alleles
      DNA sequencing of the CFTR gene CFTR-Seq   Specific mutations
      Sweat chloride Sweat-Cl 2077-6 mmol/L
      Trypsinogen I Free IRT 48633-2 ug/L
      Cystic fibrosis newborn screen interpretation   46769-6 Answer list
  Endocrine Disorders
      11-Deoxycorticosterone 11DOC 53347-1 ng/dL
      11-Deoxycortisol 11DC 53338-0 ug/dL
      17-Hydroxyprogesterone 17OHP 38473-5 ng/mL
      17-Hydroxyprogesterone+Androstenedione/Cortisol 17OCHS+Androst/Cortis 53336-4 {ratio}
      21-Deoxycortisol 21DC 53341-4 ug/dL
      Androstenedione Androst 53343-0 ng/dL
      Cortisol Cortis 53345-5 ug/dL
      Thyrotropin TSH 29575-8 m[IU]/L
      Thyroxine (T4) T4 31144-9 ug/dL
      Congenital adrenal hyperplasia newborn screen interpretation   46758-9 Answer list
      Congenital hypothyroidism newborn screen interpretation   46762-1 Answer list
  Galactosemia
      Enzyme NADPH5 NADPH5   mg/dL
      Galactose Galact 54084-9 mg/dL
      Galactose 1 phosphate uridyl transferase Gal1PUT DBS Ql 33288-2 N/A
      Galactose 1 phosphate uridyl transferase Gal1PUT DBS-cCnc 42906-8 U/g{Hb}
      Galactosemias newborn screen interpretation   46737-3 Answer list
  Hemoglobin Disorders
      Fifth most predominant hemoglobin 5th most predominant Hb DBS 64121-7 Answer list
      Fourth most predominant hemoglobin 4th most predominant Hb DBS 64120-9 Answer list
      Hemoglobin A/Hemoglobin.total %Hb A 54072-4 %
      Hemoglobin Barts/Hemoglobin.total %Hb Bart's 54069-0 %
      Hemoglobin C/Hemoglobin.total %Hb C 54073-2 %
      Hemoglobin D/Hemoglobin.total %Hb D 54070-8 %
      Hemoglobin E/Hemoglobin.total %Hb E 54071-6 %
      Hemoglobin F/Hemoglobin.total %Hb F 54074-0 %
      Hemoglobin O - Arab/Hemoglobin.total %Hb O-ARAB 54068-2 %
      Hemoglobin S/Hemoglobin.total %Hb S 56476-5 %
      Hemoglobin observations newborn screening panel Hb observations NBS pnl DBS 64116-7  
      Hemoglobins that can be presumptively identified based on available controls Hb pres ID based on avail contr DBS 64122-5 Answer list
      Most predominant hemoglobin Most predominant Hb DBS 64117-5 Answer list
      Second most predominant hemoglobin 2nd most predominant Hb DBS 64118-3 Answer list
      Third most predominant hemoglobin 3rd most predominant Hb DBS 64119-1 Answer list
      Hemoglobin disorders newborn screen interpretation   46740-7 Answer list
  Infectious Diseases
      HIV 1+2 IgG Ab HIV IgG 54086-4 Pos or Neg
      Toxoplasma gondii IgG Ab Tox IgG 54087-2 Pos or Neg
      Toxoplasma gondii IgM Ab Tox IgM 54088-0 Pos or Neg
  Lysosomal Storage Disorders
      Acid alpha glucosidase GAA 55827-0 umol/L/h
      Acid beta glucosidase GBA 55917-9 umol/L/h
      Acid sphingomyelinase ASM 62316-5 umol/L/h
      Alpha galactosidase A GLA 55908-8 umol/L/h
      Alpha-L-iduronidase (IDUA) IDUA 55909-6 umol/h/L
      Galactocerebrosidase GALC 62310-8 umol/L/h
      Mucopolysaccharidosis type I interpretation MPS I 79564-1 Answer list
  Other
      Glucose-6-Phosphate dehydrogenase G6PD 33287-4 N/A
      T-cell receptor excision circle TREC 62320-7 {copies}

The above view reflects the criteria you selected on the previous screen.

The view includes derived measures.

Legend

1

Analyte Name — the chemical whose concentration is being measured by the Dried Blood Spot testing, or the newborn hearing screening method.

2

Analyte Short Name — an abbreviation for the analyte.

3

LOINC Number — the unique and permanent code assigned by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee to identify the test measurement. LOINC codes are unique for different test methods and different units of reporting to enable interoperability and comparison of results from different labs. LOINC is a U.S. government standard for electronic health information exchange of laboratory tests and other measurements in Interoperability Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).

4

Units — what is being counted or measured, using the Unified Code for Units of MeasureExternal Web Site Policy (UCUM). Ratios whose units fully cancel each other are indicated by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such as "Pos or Neg" or "Specific alleles").